Pfizer Inc. (BMV:PFE)

Market Cap	2.49T
Revenue (ttm)	1.28T
Net Income (ttm)	161.05B
Shares Out	n/a
EPS (ttm)	28.26
PE Ratio	15.46
Forward PE	8.23
Dividend	33.53 (7.47%)
Ex-Dividend Date	Jul 25, 2025

Volume	15,278
Average Volume	25,477
Open	449.00
Previous Close	449.00
Day's Range	436.00 - 449.00
52-Week Range	427.00 - 597.50
Beta	0.50
RSI	37.22
Earnings Date	Aug 5, 2025

About United States Steel

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.